Asia Pacific Pharmaceutical Logistics Market: Market Size & Forecast 2026

The market covers end-to-end logistics services for pharmaceutical products including cold chain transport, ambient storage, and last-mile delivery across the Asia Pacific region. It represents a significant segment of the broader APAC logistics industry, which reached $2.34 trillion in 2025, and is closely tied to the region's pharmaceutical manufacturing and distribution ecosystem. The sector requires adherence to Good Distribution Practice standards and specialized infrastructure to handle temperature-sensitive and high-value medical products.

• •Valued at $163 billion in 2025, with projections to reach $238.99 billion by 2031 at a 6.6% CAGR
• •Represents a specialized subset requiring temperature control and regulatory compliance
• •Tied closely to the broader $464 billion APAC pharmaceutical industry

The market is fueled by the rapid expansion of the Asia Pacific pharmaceutical industry, which is expected to grow significantly through 2031 driven by rising healthcare expenditure and aging demographics. Increasing prevalence of chronic diseases, expanding insurance coverage, and growing domestic pharmaceutical manufacturing across China, India, and Japan are creating sustained demand for logistics services. The pharmaceutical packaging sector, valued at $1.57 billion in 2025 and projected to grow at 17.2% CAGR, further amplifies logistics demand through heightened manufacturing activity.

• •China holds approximately 36% revenue share of the broader APAC pharmaceutical market and leads regional growth
• •India and China projected to lead pharmaceutical logistics expansion with CAGRs of 7.5% and 8.1% respectively
• •Temperature-controlled logistics identified as a primary growth catalyst across the region

The market encompasses various service categories including cold chain logistics, warehousing, freight forwarding, and inventory management, with temperature-controlled distribution representing a particularly high-growth segment. China dominates the regional landscape with the largest revenue share, while India emerges as a rapidly growing market driven by pharmaceutical manufacturing expansion and healthcare infrastructure development. Japan and South Korea represent mature markets with sophisticated cold chain capabilities and stringent regulatory requirements, while Southeast Asian nations are accelerating investments in healthcare logistics.

• •China commands approximately 36% of the APAC pharmaceutical market and maintains the largest logistics infrastructure
• •Japan and South Korea operate mature markets with advanced cold chain networks and high regulatory standards
• •Southeast Asian markets are emerging as significant growth areas driven by healthcare modernization

What are the recent trends and outlook?

Digitalization and real-time supply chain visibility are transforming pharmaceutical logistics operations, with increased adoption of IoT sensors, blockchain technology, and advanced data analytics for temperature monitoring and product authentication. The market is positioned to benefit from the growing production of biologics, vaccines, and specialty medicines requiring precise environmental controls throughout extended supply chains. Sustainability initiatives and green logistics practices are gaining prominence as stakeholders seek to reduce carbon footprints while maintaining strict product integrity and regulatory compliance.

• •Cold chain infrastructure expansion remains a primary investment priority across the region
• •Digital tracking, IoT monitoring, and blockchain adoption are enhancing supply chain transparency
• •E-commerce growth in pharmaceuticals is driving demand for specialized last-mile delivery capabilities